316 related articles for article (PubMed ID: 11123898)
21. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen.
Grailhe P; Nieuwenhuizen W; Anglés-Cano E
Eur J Biochem; 1994 Feb; 219(3):961-7. PubMed ID: 8112348
[TBL] [Abstract][Full Text] [Related]
22. Studies on the localization and accessibility of sites in fibrin which are involved in the acceleration of the activation of plasminogen by tissue-type plasminogen activator.
Nieuwenhuizen W; Schielen WJ; Yonekawa O; Tesser GI; Voskuilen M
Adv Exp Med Biol; 1990; 281():83-91. PubMed ID: 2129380
[No Abstract] [Full Text] [Related]
23. Fibrinogen alpha C domains contain cryptic plasminogen and tPA binding sites.
Tsurupa G; Medved L
Ann N Y Acad Sci; 2001; 936():328-30. PubMed ID: 11460488
[TBL] [Abstract][Full Text] [Related]
24. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
25. Location of plasminogen-binding sites in human fibrin(ogen).
Váradi A; Patthy L
Biochemistry; 1983 May; 22(10):2440-6. PubMed ID: 6222763
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule.
Urano T; Takada Y; Takada A
Biochim Biophys Acta; 1991 Apr; 1077(3):245-52. PubMed ID: 1903067
[TBL] [Abstract][Full Text] [Related]
27. Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation.
Haddeland U; Sletten K; Bennick A; Nieuwenhuizen W; Brosstad F
Thromb Haemost; 1996 Feb; 75(2):326-31. PubMed ID: 8815585
[TBL] [Abstract][Full Text] [Related]
28. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
[TBL] [Abstract][Full Text] [Related]
29. Evolutionary stability of fibrinogen epitopes implicated in fibrin polymerization and in fibrinolysis.
Mirshahi M; Mirshahi SS; Soria C; Perrot JY; Guidalia M; Boucheix C; Soria J
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):427-31. PubMed ID: 2133218
[TBL] [Abstract][Full Text] [Related]
30. Binding of tissue-type plasminogen activator to fibrinogen fragments.
Bosma PJ; Rijken DC; Nieuwenhuizen W
Eur J Biochem; 1988 Mar; 172(2):399-404. PubMed ID: 3127207
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen.
Han J; Baik N; Kim KH; Yang JM; Han GW; Gong Y; Jardí M; Castellino FJ; Felez J; Parmer RJ; Miles LA
Blood; 2011 Aug; 118(6):1653-62. PubMed ID: 21680799
[TBL] [Abstract][Full Text] [Related]
32. Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation.
Nieuwenhuizen W
Thromb Res; 1994 Aug; 75(3):343-7. PubMed ID: 7992246
[TBL] [Abstract][Full Text] [Related]
33. [Binding of alpha-2-antiplasmin with fibrinogen/fibrin and their fragments independent of factor XIII].
Zadorozhna MB; Hrynenko TV; Iusova OI; Volkov HL
Ukr Biokhim Zh (1999); 2004; 76(5):71-7. PubMed ID: 16100900
[TBL] [Abstract][Full Text] [Related]
34. Beta(Leu121-Lys122) segment of fibrinogen is in a region essential for plasminogen binding by fibrin fragment E.
Váradi A; Patthy L
Biochemistry; 1984 Apr; 23(9):2108-12. PubMed ID: 6722138
[TBL] [Abstract][Full Text] [Related]
35. Analysis of fibrin formation and proteolysis during intravenous administration of ancrod.
Dempfle CE; Argiriou S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
Blood; 2000 Oct; 96(8):2793-802. PubMed ID: 11023513
[TBL] [Abstract][Full Text] [Related]
36. [Proteolytic activity of the Glu-plasminogen complex with fibrinogen fragment E].
Skomorovskaia EV; Grinenko TV; Kudinov SA; Zolotareva EN
Biokhimiia; 1991 Mar; 56(3):458-66. PubMed ID: 1883906
[TBL] [Abstract][Full Text] [Related]
37. A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator.
Kim PY; Tieu LD; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2012 Feb; 287(7):4652-61. PubMed ID: 22187433
[TBL] [Abstract][Full Text] [Related]
38. Binding of fibrin fragments to one-chain and two-chain tissue-type plasminogen activator.
Hasan AA; Chang WS; Budzynski AZ
Blood; 1992 May; 79(9):2313-21. PubMed ID: 1571544
[TBL] [Abstract][Full Text] [Related]
39. [Binding of K 1-3 and K 4 fragments of plasminogen containing lysine-binding sites with fibrinogen and its fragments].
Tret'iachenko VG; Grinenko TV; Kudinov SA
Ukr Biokhim Zh (1978); 1988; 60(2):3-6. PubMed ID: 3394172
[TBL] [Abstract][Full Text] [Related]
40. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
Cao YJ; Wu YH; Liu CF
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
